Delivery Order SPE2DB22D9239-SPE2DB25FDL08
- Not listed
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $29,829.40 for Rituxan 500 mg/50 ml vials. The delivery order was issued on September 10, 2025, with an ultimate completion date of October 1, 2025, and carries no set-aside designation. This award represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $12,276.68 contract is for the supply of Rituxan 500 mg/50 ml vial, a pharmaceutical product used for medical treatment. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $33,760.87 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Rituxan 500 mg/50 ml vial, a pharmaceutical product used in medical care. This delivery order is placed against DMS Pharmaceutical Group's existing indefinite delivery contract with DLA, contract #SPE2DB23D4600082013, which has a ceiling value of up to...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,691.70 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4565781429 RITUXAN 500 MG/50 ML VIAL 50ML to DLA's Medical Supply Chain division. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with DLA under the SPE2DB program, valued at up to $499,999,999,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $95,618.70 contract is for the delivery of Rituxan 500 mg/50 ml vials to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,965.88 by the Defense Logistics Agency on August 7, 2025. The contract calls for the delivery of Rituxan 500 mg/50 ml vials, a biologic medication commonly used in oncology and rheumatology treatments. This delivery order was issued without a set-aside designation, and performance is scheduled for completion by August...
- On June 2, 2025, the Defense Logistics Agency awarded a delivery order valued at $11,931.76 to DMS Pharmaceutical Group Inc. for the supply of Rituxan 500 mg/50 ml vials. This firm fixed-price delivery order, with an ultimate completion date of June 24, 2025, represents a continuation of pharmaceutical supply services under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract was awarded without a set-aside designation, and the product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Rituxan 500 mg/50 ml vials. This firm fixed-price delivery order, valued at $11,931.76, was awarded on September 17, 2025, with an ultimate completion date of October 8, 2025. The contract does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $19,227.00 firm fixed-price delivery order is for the supply of RITUXAN 500 MG/50 ML VIAL 50ML, with a period of performance ending on November 18, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $38,347.10 to the woman-owned small business DMS Pharmaceutical Group Inc. based in Park Ridge, Illinois. The order is for the pharmaceutical product Rituxan 500 mg/50 ml vial and has a completion date of February 28, 2023. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA to issue...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL08Delivery Order
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $5,965.88 to DMS Pharmaceutical Group Inc. for the supply of Rituxan 500 mg/50 mL vials on August 12, 2025. This delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, which is valued at approximately $500 million and extends through November 2026. The award carries no set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois, to compete directly in federal procurement markets. Rituxan is a monoclonal antibody used in the treatment of certain cancers and autoimmune conditions, reflecting the broader scope of specialty pharmaceutical products the DLA procures to support military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables. The company's IDC with the DLA under the SPE2DB program enables the agency to issue firm fixed-price delivery orders for diverse pharmaceutical needs across military health facilities worldwide. As a woman-owned small business pharmaceutical wholesaler registered in SAM.gov since 2001, DMS Pharmaceutical Group leverages its status to compete effectively while providing comprehensive distribution services that support the Department of Defense's medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 8/12/25 |